INTRODUCTION AND OBJECTIVES:
To evaluate the impact of distal ureter management on oncological results after Laparoscopic/ Robotic nephroureterectomy comparing intra-corporeal versus open extra-vesical bladder cuff excision METHODS: We retrospectively collected data from 250 patients who underwent Laparoscopic/Robotic nephroureterectomy for upper urinary tract urothelial carcinoma from 2003 to 2013. Patients were divided into two subgroups according to the type of operation performed. Group A comprised 130 patients who had laparoscopic nephroureterectomy with open resection of the bladder cuff. Group B comprised 120 patients in whom received intra-corporeal bladder cuff excision. The mean operative time, hospital stay, duration of catheterisation, bladder recurrence rates, and cancer-specific survival (CSS) were assessed.
RESULTS: The total operative time was statistically significantly less in the Group B (intra-corporeal BCE). There was no statistical difference between Groups A and B for the bladder recurrence rate (Group A 10% vs 8% in Group B, P [ 0.51). There was no difference in CSS at the 5-year follow-up.
CONCLUSIONS: Laparoscopic/Robotic nephroureterectomy with intra-corporeal bladder cuff excision is an oncologically safe and technically feasible operation.
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MP37-20 ARE URINE CYTOLOGY, RETROGRADE PYELOGRAPHY, AND URETEROSCOPY STILL ROUTINELY-REQUIRED FOR ALL PATIENTS WITH UPPER TRACT UROTHELIAL CANCER IN THE MODERN ERA OF CROSS-SECTIONAL IMAGING?
Mohamed Elawdy*, Diaa Eldin Taha, Rasha T. Abouelkheir, Ebrahim Elsaeed, Mohamed Abd El-Hamid, Yasser Osman, Mansoura, Egypt INTRODUCTION AND OBJECTIVES: The diagnostic workup of the upper tract urothelial cancer (UTUC) has been known to be intravenous urography (IVU), cytology, retograde pyelography (RP), ureteroscopy (URS), and URS biopsy. With recent advances in Multidector CT (MDCT) and MRI and improved accuracy that reached 97%, a new diagnostic algorithm for patients with suspected UTUC is required.
METHODS: After institutional review board approval, we retrospectively reviewed our ongoing database for patients who had undergone surgery for UTUC from 1990 to 2016. We looked for and reviewed all data on cytology, retrograde pyelography, ureteroscopic (URS) biopsy, and MDCT / MRI reports -all were compared to the final histopathological reports. Samples for cytologic examination were obtained by ureteric catheterization, and biopsy was taken by 3F cup forceps. Standard open radical nephroureterectomy procedure was performed for the majority and laparoscopic approach were performed in select cases. The tumor was staged according to the 1997 TNM classification. The conventional 3-tiered WHO grading system was used. Analysis was done using IBM SPSSÒ version 22.
RESULTS: There were 275 patients, and 87% were male. Cytology had an overall accuracy of 76% and retrograde gave positive findings in 94%. Ureteric biopsies were performed in 124 patients with overall 87% accuracy for pelvicalyceal and ureteral tumor, reached 93% in the cohort of ureteral tumors. The accuracy of combined use of cytology, RP, URS, and URS biopsy was 98%. Complete data on MDCT / MRI was available for 270, with accuracy of 96%, with no false positive cases as proved by the final histopathology. Six false negative cases (2 pelvicalyceal, and 4 ureteric ) which were reported free of tumors by imaging and had cancer proved by the histopathology; three cases had cytology and URS biopsy that showed TCC, 1 case had SCC of the renal pelvis and the remaining 2 cases were operated based on significant hydronephrosis and lost renal parenchyma.
CONCLUSIONS: For radiologically-confirmed UTUC, and if radical surgery is indicated, the decision can be made on the results of MDCT/ MRI. However, in cases of doubt, or when conservative management is indicated, combined use of the other tools, such as cytology, RP, URS, and biopsy is warranted. 
